Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
177Lu-Satoreotide by Ariceum Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval
177Lu-Satoreotide is under clinical development by Ariceum Therapeutics and currently in Phase I for Small-Cell Lung Cancer. According to GlobalData,...